Amphastar Pharmaceuticals, Inc.
AMPH · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $17,350 | $31,030 | $25,285 | $37,964 |
| Dep. & Amort. | $14,129 | $13,018 | $15,207 | $14,664 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $6,297 | $6,382 | $8,393 | $5,632 |
| Change in WC | $11,997 | -$18,525 | -$16,714 | -$8,590 |
| Other Non-Cash | $2,810 | $3,687 | $2,906 | -$20,646 |
| Operating Cash Flow | $52,583 | $35,592 | $35,077 | $29,024 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$5,348 | -$10,565 | -$10,697 | -$12,411 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$35,206 | -$8,509 | -$7,110 | -$29,285 |
| Inv. Sales/Matur. | $22,527 | $23,034 | $28,288 | $7,484 |
| Other Inv. Act. | -$1,592 | -$4,585 | $0 | -$1,466 |
| Investing Cash Flow | -$19,619 | -$625 | $10,481 | -$35,678 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $124 | $3,839 | $1,604 | $4,753 |
| Stock Issued | -$494 | $494 | $0 | $0 |
| Stock Repurch. | $50,220 | -$39,220 | -$11,000 | -$42,002 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$54,197 | $4,685 | -$5,107 | $3,407 |
| Financing Cash Flow | -$4,347 | -$30,202 | -$14,503 | -$33,842 |
| Forex Effect | -$41 | $142 | $118 | -$11 |
| Net Chg. in Cash | $28,576 | $4,907 | $31,173 | -$40,507 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $187,924 | $183,017 | $151,844 | $192,351 |
| End Cash | $216,500 | $187,924 | $183,017 | $151,844 |
| Free Cash Flow | $47,235 | $25,027 | $24,380 | $16,613 |